Waters reported Q2 non-GAAP EPS of $3.05 and revenue of $1.65 billion, exceeding analyst expectations by $0.04 and $30M respectively.
Waters Corp posted Q2 non-GAAP earnings per share of $3.05, beating estimates by $0.04, while revenue surged 114% year-over-year to $1.65 billion, $30M above forecasts. The company attributed the outperformance to broad-based organic growth across its segments.
Total reported revenue of $1.645 billion surpassed the high end of the guidance range, reflecting strong demand in its core markets. Analysts had anticipated revenue closer to $1.62 billion and EPS near $3.01 for the quarter.
The results highlight Waters’ momentum in analytical instruments and laboratory solutions, driven by increased spending in pharmaceuticals and biotechnology sectors.